Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 07, 2017 17:00 ET | Source: Avivagen Inc.

Avivagen Announces Chief Executive Officer and Issuance of Third Quarter Results

OTTAWA, Sept. 07, 2017 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV) (OTC Pink:CHEXF) (Avivagen or the Corporation), a corporation with a proven and commercially-ready, patent-protected product...
August 16, 2017 07:30 ET | Source: Avivagen Inc.

Avivagen Announces Scale Up of Commercial Roll Out for OxC-beta™ Livestock in the Philippines

OTTAWA, Ontario, Aug. 16, 2017 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV) (OTC Pink:CHEXF) (“Avivagen” or the “Corporation”), a corporation with a proven and commercially-ready, patent-protected...
July 10, 2017 07:30 ET | Source: Avivagen Inc.

Cesar Millan to Endorse Avivagen’s Companion Animal Health Product Vivimune Health Chews

OTTAWA, July 10, 2017 (GLOBE NEWSWIRE) -- Avivagen Inc. (“Avivagen” or the “Corporation” (TSX-V:VIV) (OTC Pink:CHEXF), a life sciences innovation company with a series of patent protected products...
July 04, 2017 08:00 ET | Source: Avivagen Inc.

Avivagen Retains Hybrid Financial Inc. for Investor Relations Activities

OTTAWA, July 04, 2017 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSX-V:VIV) (OTC Pink:CHEXD) (“Avivagen” or the “Corporation”), a corporation with a proven and commercially-ready, patent-protected product...
June 05, 2017 08:00 ET | Source: Avivagen Inc.

Avivagen Provides Business Updates

OTTAWA, June 05, 2017 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSX-V:VIV) (OTC Pink:CHEXF) (“Avivagen” or the “Corporation”), a corporation with a proven and commercially-ready, patent-protected product...
May 30, 2017 13:20 ET | Source: Avivagen Inc.

Avivagen Announces Grant of Stock Options

OTTAWA, May 30, 2017 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV) (OTC Pink:CHEXF), a life sciences company commercializing products to replace the antibiotics used in livestock feeds, is...
May 26, 2017 09:35 ET | Source: Avivagen Inc.

Avivagen Announces Third Purchase Order of OxC-Beta™ Livestock from UNAHCO Inc.

OTTAWA, May 26, 2017 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV) (OTC Pink:CHEXF) (Avivagen or the Corporation), a corporation with a proven and commercially-ready, patent protected product...
May 24, 2017 16:00 ET | Source: Avivagen Inc.

Avivagen Announces Completion of Share Consolidation

OTTAWA, May 24, 2017 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV) (OTC Pink:CHEXF) (Avivagen or the Corporation), a Corporation with a proven and commercially-ready, patent-protected product...
May 12, 2017 08:00 ET | Source: Avivagen Inc.

Avivagen Announces Engagement of Regulatory Consulting Firm

OTTAWA, Ontario, May 12, 2017 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV) (OTC Pink:CHEXF) (Avivagen or the Corporation), a Corporation with a proven and commercially-ready, patent-protected...
May 08, 2017 14:07 ET | Source: Avivagen Inc.

Avivagen Inc. Announces Consolidation of Common Shares

OTTAWA, Ontario, May 08, 2017 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV), (OTC Pink:CHEXF) (Avivagen or the Corporation), a company with a proven and commercially-ready, patent-protected product...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right